Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
31.01.24
/
50%
€63.60
Target price
31.01.25
€79.15
Performance (%)
9.28%
Price
08:00
€69.50
Summary
This prediction is currently active. With a performance of 9.28%, the BUY prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc. is trending in the right direction. This prediction currently runs until 31.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 1.471% | 1.471% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $86.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
11.20%
08:00
08:00
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€79.43
23.02.25
23.02.25
7.25%
08:00
08:00
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.40
03.11.23
03.11.23
€70.83
03.11.24
03.11.24
30.35%
08:00
08:00
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
29.91%
08:00
08:00
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24